The Lancet. Respiratory medicine
In control of ambient and household air pollution - how low should we go?
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Clinical trials in acute respiratory distress syndrome: challenges and opportunities.
Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome.
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial.
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.
